Erratum: Effect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population (Medical Oncology (2011) DOI: 10.1007/s12032-011-9980-2);Effect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population

Medical Oncology

Volumn 29, Issue 2, 2012, Pages 1044-1049

  Daraei, A ^a   Salehi, R ^a   Salehi, M ^a   Emami, M H ^b,c   Jonghorbani, M ^b   Mohamadhashem, F ^a   Tavakoli, H ^b,c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Poursina Hakim Research Institute   (Iran)

Author keywords

8q24 region; EGF; Single nucleotide polymorphisms; Sporadic CRC

Indexed keywords

EPIDERMAL GROWTH FACTOR; DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHROMOSOME 8Q; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; IRAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SPORADIC COLORECTAL CANCER; CANCER STAGING; CHROMOSOME 8; COLON; COLORECTAL TUMOR; COMPARATIVE STUDY; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; HUMAN CHROMOSOME; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RECTUM; RISK FACTOR;

CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN; CHROMOSOMES, HUMAN, PAIR 8; COLON; COLORECTAL NEOPLASMS; DNA, NEOPLASM; EPIDERMAL GROWTH FACTOR; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRAN; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECTUM; RISK FACTORS;

EID: 84864407219     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-0039-1     Document Type: Erratum

References (30)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.
2. Fahy B, Bold RJ. Epidemiology and molecular genetics of colorectal cancer. Surg Oncol. 1998;7(3-4):115-23.
3. Cappell MS. Pathophysiology, clinical presentation, and management of colon cancer. Gastroenterol Clin North Am. 2008; 37(1):1-24.
4. Aaltonen L, Johns L, Jarvinen H, Mecklin JP, Houlston R. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin Cancer Res. 2007;13(1):356-61.
5. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med. 1998;338(21):1481-7.
6. Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ. 2006;333(7568):597-600.
7. Zintzaras E. The generalized odds ratio as a measure of genetic risk effect in the analysis and meta-analysis of association studies. Stat Appl Genet Mol Biol. 2010;9(1):50.
8. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343(2):78-85.
9. Li D, Conti DV. Detecting gene-environment interactions using a combined case-only and case-control approach. Am J Epidemiol. 2009;169(4):497-504.
10. Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, et al. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA. 2008;299(20):2423-36.
11. Harismendy O, Frazer KA. Elucidating the role of 8q24 in colorectal cancer. Nat Genet. 2009;41(8):868-9.
12. Tuupanen S, Niittymaki I, Nousiainen K, Vanharanta S, Mecklin JP, et al. Allelic imbalance at rs6983267 suggests selection of the risk allele in somatic colorectal tumor evolution. Cancer Res. 2008;68(1):14-7.
13. Zanke BW, Greenwood CM, Rangrej J, Kustra R, Tenesa A, et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet. 2007;39(8): 989-94.
14. Wokolorczyk D, Gliniewicz B, Sikorski A, Zlowocka E, Masojc B, et al. A range of cancers is associated with the rs6983267 marker on chromosome 8. Cancer Res. 2008;68(23):9982-6.
15. Cicek MS, Slager SL, Achenbach SJ, French AJ, Blair HE, et al. Functional and clinical significance of variants localized to 8q24 in colon cancer. Cancer Epidemiol Biomarkers Prev. 2009;18(9): 2492-500.
16. Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol. 1995;19(3):183-232.
17. Price PM, Megyesi J, Saggi S, Safirstein RL. Regulation of transcription by the rat EGF gene promoter in normal and ischemic murine kidney cells. Am J Physiol. 1995;268(4 Pt 2): F664-70.
18. De Boer WI, Houtsmuller AB, Izadifar V, Muscatelli-Groux B, Van der Kwast TH, et al. Expression and functions of EGF, FGF and TGFbeta-growth-factor family members and their receptors in invasive human transitional-cell-carcinoma cells. Int J Cancer. 1997;71(2):284-91.
19. Henson ES, Gibson SB. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal. 2006;18(12):2089-97.
20. Siena S, Sartore-Bianchi A, Di Nicolantonio F, Balfour J, Bardelli A. Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J Natl Cancer Inst. 2009;101(19):1308-24.
21. Spindler KL, Nielsen JN, Ornskov D, Brandslund I, Jakobsen A. Epidermal growth factor (EGF) A61G polymorphism and EGF gene expression in normal colon tissue from patients with colorectal cancer. Acta Oncol. 2007;46(8):1113-7.
22. Wu GY, Hasenberg T, Magdeburg R, Bonninghoff R, Sturm JW, et al. Association between EGF, TGF-beta1, VEGF gene polymorphism and colorectal cancer. World J Surg. 2009;33(1): 124-9.
23. McCarron SL, Bateman AC, Theaker JM, Howell WM. EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma. Int J Cancer. 2003;107(4): 673-5.
24. Kim YJ, Lee HS, Im JP, Min BH, Kim HD, et al. Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med. 2003;35(3):196-202.
25. Vishnoi M, Pandey SN, Modi DR, Kumar A, Mittal B. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1-509C>T gene polymorphisms with gallbladder cancer. Hum Immunol. 2008;69(6): 360-7.
26. Gao LB, Wei YS, Zhou B, Wang YY, Liang WB, et al. No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma. Cancer Genet Cytogenet. 2008;185(2):69-73.
27. Ribeiro R, Soares A, Pinto D, Catarino R, Lopes C, et al. EGF genetic polymorphism is associated with clinical features but not malignant phenotype in neurofibromatosis type 1 patients. J Neurooncol. 2007;81(3):225-9.
28. Araujo AP, Ribeiro R, Pinto D, Pereira D, Sousa B, Ma A, et al. Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease. DNA Cell Biol. 2009;28(5): 265-9.
29. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, et al. A common variant associated with prostate cancer in European and African populations. Nat Genet. 2006;38(6):652-8.
30. Berndt SI, Potter JD, Hazra A, Yeager M, Thomas G, et al. Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk. Hum Mol Genet. 2008;17(17):2665-72.